Dasatinib enhances migration of monocyte-derived dendritic cells by reducing phosphorylation of inhibitory immune receptors Siglec-9 and Siglec-3. [electronic resource]
Producer: 20141108Description: 773-82.e1-3 p. digitalISSN:- 1873-2399
- Antigens, CD -- immunology
- CD8-Positive T-Lymphocytes -- cytology
- Cell Communication -- drug effects
- Cells, Cultured
- Chemokine CCL19 -- immunology
- Chemotaxis -- drug effects
- Cytomegalovirus -- immunology
- Dasatinib
- Dendritic Cells -- cytology
- Female
- Gene Expression Regulation -- drug effects
- Humans
- Interleukin-12 -- immunology
- Male
- Monocytes -- cytology
- Phosphorylation -- drug effects
- Protein Kinase Inhibitors -- pharmacology
- Pyrimidines -- pharmacology
- Receptors, CCR7 -- immunology
- Sialic Acid Binding Ig-like Lectin 3 -- immunology
- Sialic Acid Binding Immunoglobulin-like Lectins -- immunology
- Thiazoles -- pharmacology
- src-Family Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.